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It has been brought to our attention that some paragraphs in
the Introduction and Discussion of our recent research article
[1] show close similarities to paragraphs in recent
publications by Oh et al. [2] and Holloway et al. [3]. While
these publications were referenced elsewhere in our paper,
the paragraphs which show similarities were not specifically
referenced.
We regret this and offer our apologies to the authors.
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